Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
PUT
BioMarin Pharmaceuticals
BMRN
$12.4B
| $2.88M | ﹤0.01% |
32,800
-9,300
| -22% | -$827K |
|
1727
Helmerich & Payne
HP
$3.71B
| $2.88M | ﹤0.01% |
43,180
-74,027
| -63% | -$5.27M |
|
1728
CALL
GameStop
GME
$8.6B
| $2.87M | ﹤0.01% |
509,600
+258,800
| +103% | +$1.58M |
|
1729
PUT
Occidental Petroleum
OXY
$55.9B
| $2.86M | ﹤0.01% |
45,200
-162,500
| -78% | -$10.8M |
|
1730
PUT
Targa Resources
TRGP
$55.1B
| $2.86M | ﹤0.01% |
47,800
+32,166
| +206% | +$1.87M |
|
1731
CALL
LyondellBasell Industries
LYB
$19.2B
| $2.85M | ﹤0.01% |
31,300
-114,400
| -79% | -$10.4M |
|
1732
HSBC
HSBC
$356B
| $2.85M | ﹤0.01% |
77,308
+27,907
| +56% | +$1.05M |
|
1733
Weibo
WB
$1.95B
| $2.84M | ﹤0.01% |
54,470
+10,273
| +23% | +$511K |
|
1734
Sarepta Therapeutics
SRPT
$1.77B
| $2.84M | ﹤0.01% |
95,819
+16,109
| +20% | +$499K |
|
1735
CALL
Hain Celestial
HAIN
$53.7M
| $2.83M | ﹤0.01% |
76,200
-48,100
| -39% | -$1.81M |
|
1736
Ligand Pharmaceuticals
LGND
$6.36B
| $2.83M | ﹤0.01% |
42,903
+1,658
| +4% | +$109K |
|
1737
Allegiant Air
ALGT
$2.57B
| $2.83M | ﹤0.01% |
17,671
+14,570
| +470% | +$2.45M |
|
1738
PUT
Melco Resorts & Entertainment
MLCO
$2.14B
| $2.83M | ﹤0.01% |
152,600
+88,600
| +138% | +$1.52M |
|
|
1739
PUT
Hain Celestial
HAIN
$53.7M
| $2.83M | ﹤0.01% |
76,000
+33,600
| +79% | +$1.26M |
|
|
1740
Melco Resorts & Entertainment
MLCO
$2.14B
| $2.83M | ﹤0.01% |
152,495
+115,949
| +317% | +$1.99M |
|
|
GRUB
1741
CALL
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $2.83M | ﹤0.01% |
42,950
+42,900
| +85,800% | +$3.17M |
|
1742
PUT
ProShares UltraPro Short QQQ
SQQQ
$1.71B
| $2.82M | ﹤0.01% |
30
-1
| -3% | -$104K |
|
1743
Shutterstock
SSTK
$219M
| $2.81M | ﹤0.01% |
68,083
+18,985
| +39% | +$905K |
|
1744
CALL
Cencora
COR
$61.2B
| $2.81M | ﹤0.01% |
31,800
-15,800
| -33% | -$1.39M |
|
|
LEXEA
1745
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $2.8M | ﹤0.01% |
61,636
-60,093
| -49% | -$2.64M |
|
1746
CALL
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.55B
| $2.8M | ﹤0.01% |
77,000
-29,300
| -28% | -$1.02M |
|
|
SVU
1747
DELISTED
SUPERVALU Inc.
SVU
| $2.79M | ﹤0.01% |
103,244
+96,129
| +1,351% | +$2.63M |
|
|
1748
CALL
HSBC
HSBC
$356B
| $2.79M | ﹤0.01% |
75,608
-32,435
| -30% | -$1.22M |
|
1749
WD-40
WDFC
$3.15B
| $2.79M | ﹤0.01% |
25,589
+18,126
| +243% | +$1.97M |
|
1750
PUT
NetApp
NTAP
$37.2B
| $2.78M | ﹤0.01% |
66,500
-164,200
| -71% | -$6.47M |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.